Edward J. Benz Jr., Richard and Susan Smith Professor of Medicine and chief executive of Dana-Farber Cancer Institute, announced that he would step down as CEO at Dana-Farber after a 16-year run that saw the specialty hospital become a fund-raising powerhouse and change from a regional center to an international destination for cancer research and treatment.
Read the full article
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?